Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Brain-friendly amperometric enzyme biosensor based on encapsulated oxygen generating biomaterial.
Damon Runyon Cancer Research Foundation Fellowship
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.
Hand grip strength, standing balance, and rapid foot tapping in relation to the menopausal transition in Campeche, Mexico.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Cachia D, Izzy S, Berriosmorales I, Ionete C. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Anti-Inflammatory Agents
Diagnosis, Differential
Female
Humans
Methylprednisolone
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Natalizumab
Prednisone
Rituximab
Thrombocytopenia
authors with profiles
Carolina Ionete MD, PhD
David M Cachia MD
Idanis M Berrios Morales MD